Oaktree Acquisition Corp. III Life Sciences (OACC) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2025
Loading P/E history...
OACC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Oaktree Acquisition Corp. III Life Sciences (OACC) trades at a price-to-earnings ratio of 195.8x, with a stock price of $10.61 and trailing twelve-month earnings per share of $0.27.
The current P/E is 292% above its 5-year average of 50.0x. Over the past five years, OACC's P/E has ranged from a low of 50.0x to a high of 50.0x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.1x, OACC trades at a 1389% premium to its sector peers. The sector includes 775 companies with P/E ratios ranging from 0.0x to 195.8x.
Relative to the broader market, OACC commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OACC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OACC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 3.6Lowest | -Best | +307%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
OACC Historical P/E Data (2025–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $10.51 | $0.21 | 50.0x | +0% |
Average P/E for displayed period: 50.0x
See OACC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OACC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OACC vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonOACC — Frequently Asked Questions
Quick answers to the most common questions about buying OACC stock.
Is OACC stock overvalued or undervalued?
OACC trades at 195.8x P/E, above its 5-year average of 50.0x. The 100th percentile ranking indicates a premium to historical valuation.
How does OACC's valuation compare to peers?
Oaktree Acquisition Corp. III Life Sciences P/E of 195.8x compares to sector median of 13.1x. The premium reflects expected growth above peers.
What is OACC's PEG ratio?
OACC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2025.